SAFE-PD

RESEARCH STUDY

Home ❯ Clinical Trials ❯ SAFE-PD
A randomised controlled trial to reduce the risk of falling in people with Parkinson’s disease

STEPPING TO AVOID FALLS EVENTS IN PARKINSON’S DISEASE

Researchers at Neuroscience Research Australia (NeuRA) and The University of New South Wales are seeking research volunteers to help us learn about reactive and volitional step training to reduce falls among people with Parkinson’s disease.

Would the research project be a good fit for me?

The study might be a good fit for you if:

  • Have been diagnosed with Parkinson’s disease (mild to moderate stage of the disease)
  • Aged 40 years or older
  • Living independently in the community or retirement village
  • Able to communicate in English language
  • Do not have a diagnosis of other neurological and/or cognitive impairments, atypical Parkinsonism
  • No recent history (< 6months) of deep-brain stimulation surgery
  • Able to walk 30 metres unassisted
  • Have had less than 20 falls in the past three months
  • Being stable on anti-Parkinson medications for >= 1 month

EXPRESSION OF INTEREST

What would happen if I took part in the research project?

If you decide to take part you would:

  • Be invited to visit NeuRA to assess your physical functions, clinical status, reactive stepping and brain functioning (non-invasively) (option to have some of the assessments conducted in your home); these assessments will be repeated after 3 months and you will receive summary results of these assessments
  • Be randomly allocated to one of two groups: one group will undertake 3 months of training, including a volitional step training program in your home plus 2 sessions of reactive step training at NeuRA. The other group will continue with their usual activities for 3 months.

Will I be paid to take part in the research project?

You may be reimbursed for any reasonable travel costs associated with the research project visit/s.

Contact

If you would like more information or are interested in being part of the study please contact

Contact person: Paulo Pelicioni
email: p.pelicioni@neura.edu.au
Phone: 02 9399 1024

HREC Approval Number: 180129

Volitional step training at home

Reactive step training at NeuRA

 

See what’s going on at NeuRA

FEEL THE BUZZ IN THE AIR? US TOO.

The importance of medical research - Professor Peter Schofield AO

On August 11 2019, 54 people took on the City2Surf for Neuroscience Research Australia (NeuRA). The event is the world’s largest fun run with 80,000 participants taking on the 14km course, which stretches from Hyde Park in central Sydney to the iconic Bondi Beach. NeuRA thanks all of its fundraisers, who raised an incredible $30,903.  This funding will further NeuRA’s […]

Gabrielle Hunter
NeuRA BLOG: Team NeuRA at the City2Surf 2019

Entering the vital next phase in our fight against Alzheimer’s

‘Take care of all your memories… for you cannot relive them.’ The words of the American singer-songwriter Bob Dylan are so true… for you cannot relive them. For Amanda, a big turning point was the moment a test showed she carried the family’s early-onset Alzheimer’s gene. Would she see her 50th birthday? And would her most treasured family memories fade away like an old album of yellowing photos? Another turning point was her vow to take part in a large clinical trial in the hope of sparing her children’s lives, since they had a 50% chance of carrying the gene too. “Sign me up... I’m your girl”, she said. The day-by-day pressure on Amanda’s life in her Alzheimer’s clinical trial has been enormous. And her bravery and endurance only heighten the pressure on us to keep up – and intensify – the fight against the hideous disease of Alzheimer’s.
APPEAL
Donor Morning Tea
Australian research shows air pollution associated with higher risk of dementia globally

The Genomics of Intellectual Disability

Neurocognitive disorders are one of the largest unmet challenges in healthcare, due to their lifelong nature, high management costs, prevalence and frequent recurrence within families. The objectives of this research will be to enhance fundamental knowledge about the genetic basis of neurocognition and the investigation of targeted treatment strategies in relation to biological pathways. Non-coding and copy number variation mechanisms will be explored along, with a study on variable expressivity and non-penetrance in specific syndromes. It will apply genomic technologies to a cohort of at least 200 families with neurocognitive disorders, develop bioinformatics tools and implement functional studies using induced pluripotent stem cells and CRISPR/Cas9 to explore the heterogeneity underlying the genetic aetiology of intellectual disability. The outcomes of this research could enable improvements in clinical phenotyping, genomic diagnosis, common data analysis and reporting standards.
PROJECT
VOLUNTEER
SUPPORT OUR RESEARCH
STUDENTS
CAREERS